Heart Disease News and Research

Latest Heart Disease News and Research

Rates of hospital emergency department use greater among women and low-income, older and rural Americans

Americans age 18 and older made over 98 million trips to hospital emergency departments in 2008 for problems ranging from broken bones to heart attacks, according to the latest News and Numbers from the Agency for Healthcare Research and Quality. This represents 78 percent of the overall nearly 125 million visits that year.

23 Nov 2010

ADA systematic review provides nutrition practice guidelines to support people with diabetes

Proper nutrition therapy is essential for the successful management of type 1 and type 2 diabetes and registered dietitians (RDs) can play a key role as part of the health care team.

23 Nov 2010

GFAP levels predict brain injury, death in critically ill children on ECMO

Johns Hopkins Children's Center scientists have discovered that high blood levels of a protein commonly found in the central nervous system can predict brain injury and death in critically ill children on a form of life support called extra-corporeal membrane oxygenation or ECMO.

23 Nov 2010

Scientists make breakthrough in techniques for exploring faults in 'smooth' muscles

Clues to the causes of serious, and often fatal, diseases and conditions, such as heart disease, stroke and high blood pressure, are being investigated at the Universities of Strathclyde and Glasgow, both in Scotland, with the use of a -1 million grant.

23 Nov 2010

Researchers investigate ways to counteract unhealthy effects of fat

A fat yet muscular mouse is helping researchers learn whether more muscle improves the cardiovascular health of obese individuals. We are looking for ways to counteract the unhealthy effects of fat, said Dr. David Stepp, vascular biologist at the Medical College of Georgia Vascular Biology Center and co-director of MCG's Diabetes & Obesity Discovery Institute.

23 Nov 2010

Frequent hemodialysis improves left ventricular mass, physical health than conventional treatment

Frequent hemodialysis improved left ventricular mass (heart size) and self-reported physical health compared to conventional hemodialysis for kidney failure, according to the Frequent Hemodialysis Network (FHN) Daily Trial funded by the National Institutes of Health and the Centers for Medicare & Medicaid Services.

23 Nov 2010

Genzyme issues Award of Excellence to Shanghai ChemPartner

ShangPharma Corporation a leading China-based pharmaceutical and biotechnology research and development outsourcing company, today announced that its wholly-owned contract research subsidiary, Shanghai ChemPartner, received an Award of Excellence from Genzyme.

23 Nov 2010

HIV drugs lead to insulin resistance

The same powerful drugs that have extended the lives of countless people with HIV come with a price - insulin resistance that can lead to diabetes and cardiovascular disease.

23 Nov 2010

Hemispherx announces publication of Ampligen Phase III data in Journal of Applied Research

Hemispherx Biopharma, Inc., announced the publication of a peer-reviewed article providing new data on Ampligen [rintatolimod; poly(I)·poly(C12,U)], an experimental therapeutic in Phase III clinical testing, in the current issue of The Journal of Applied Research.

23 Nov 2010

Arthritis Foundation, Covidien join forces to help Americans suffering from osteoarthritis

The Arthritis Foundation and Covidien have joined forces to help advance awareness and support for millions of people suffering from osteoarthritis in the United States.

23 Nov 2010

Dangers of excess fructose

More and more people have become aware of the dangers of excessive fructose in diet. A new review on fructose in an upcoming issue of the Journal of the American Society of Nephrology (JASN) indicates just how dangerous this simple sugar may be.

23 Nov 2010

Medtronic enters merger agreement to acquire Ardian

Medtronic, Inc. and privately-held Ardian, Inc. announced today that they have entered into a merger agreement whereby Medtronic will acquire Ardian.

22 Nov 2010

Asbestos awareness important to prevent related cancer: Experts

Experts from Perth speculate Western Australia is yet to see the peak of asbestos-induced cancer, with renovators still failing to take proper precautions. According to director of the National Centre for Asbestos Related Diseases, Bruce Robinson, the next and third wave of mesothelioma patients would come out of those putting themselves and others at risk while taking on DIY home renovation projects.

22 Nov 2010

North Sunflower Medical Center to deploy McKesson health IT solutions

As part of its mission to become the first critical access hospital in Mississippi to demonstrate meaningful use of electronic health record EHR) technology, North Sunflower Medical Center plans to deploy a suite of McKesson information technology solutions. The new systems will replace paper-based records and disparate technologies and address duplicate data entry challenges with communications capabilities designed to automate outdated manual processes and better coordinate care.

22 Nov 2010

Omthera reaches agreement with FDA on SPA for Epanova Phase III trial in patients with very high triglycerides

Omthera Pharmaceuticals, Inc., a privately-held emerging specialty pharmaceuticals company, today announced that it has reached an agreement with the U.S. Food and Drug Administration (FDA) on a Special Protocol Assessment (SPA) for the design of its planned Phase III registration clinical trial of Epanova™, the Company's lead compound for the treatment of patients with very high triglycerides. Epanova is an Omega 3 fatty acid containing a novel formulation of eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA).

22 Nov 2010

Profil Institute expands capabilities to detect cardiac safety signals in diabetes and obesity clinical trials

Profil™ Institute for Clinical Research, Inc., a company specializing in early phase clinical trials for diabetes and obesity, announced today the expansion of its capabilities for cardiac safety and cardiovascular efficacy studies in the company's early phase diabetes and obesity clinical trials.

22 Nov 2010

Interim results from H.P. Acthar Gel study in patients with advanced diabetic nephropathy

On November 20 at the American Society of Nephrology 43rd Annual Meeting, interim results presented from an ongoing, randomized prospective study conducted independently by James A. Tumlin, MD, at the University of Tennessee College of Medicine Chattanooga indicated that 9 of 15 patients (60%) with advanced diabetic nephropathy who are currently enrolled in the study and have completed or are still undergoing a six month course of treatment with H.P. Acthar ® Gel have exhibited a clinically significant decrease in proteinuria and achieved stabilized renal function.

22 Nov 2010

Stealth Peptides introduces Bendavia clinical candidate at AHA Scientific Sessions

Stealth Peptides, a privately held biopharmaceutical company developing innovative mitochondrial therapies for diseases with significant unmet medical needs, introduced its lead clinical candidate, Bendavia, a novel compound that targets the mitochondrion, at the 2010 American Heart Association's (AHA) Scientific Sessions, Resuscitation Science Symposium.

22 Nov 2010

New study links high prevalence of insomnia and poor quality of life in software engineers

Insomnia is bad news for software engineers' quality of life and deserves greater recognition and attention, according to new research by Sara Sarrafi Zadeh and Khyrunnisa Begum from the University of Mysore in India. Their work shows that poor sleep has a bearing on quality of life - affecting physical and mental health in particular - in this group with high levels of job-related stress. Their paper is published online in Springer's journal Applied Research in Quality of Life.

22 Nov 2010

VYTORIN reduces major vascular events in patients with chronic kidney disease

In a new investigational study of VYTORIN, the cholesterol-lowering medicine from Merck, VYTORIN 10/20 mg reduced the incidence of first major vascular events defined as non-fatal heart attacks or cardiac death, stroke or any revascularization procedure by a highly statistically significant 16.1 percent compared to placebo, Study of Heart and Renal Protection study involved more than 9,000 patients who, on average, had advanced or end-stage chronic kidney disease (CKD)

22 Nov 2010

Heart Disease News and Research

Latest Heart Disease News and Research

Rates of hospital emergency department use greater among women and low-income, older and rural Americans

ADA systematic review provides nutrition practice guidelines to support people with diabetes

GFAP levels predict brain injury, death in critically ill children on ECMO

Scientists make breakthrough in techniques for exploring faults in 'smooth' muscles

Researchers investigate ways to counteract unhealthy effects of fat

Frequent hemodialysis improves left ventricular mass, physical health than conventional treatment

Genzyme issues Award of Excellence to Shanghai ChemPartner

HIV drugs lead to insulin resistance

Hemispherx announces publication of Ampligen Phase III data in Journal of Applied Research

Arthritis Foundation, Covidien join forces to help Americans suffering from osteoarthritis

Dangers of excess fructose

Medtronic enters merger agreement to acquire Ardian

Asbestos awareness important to prevent related cancer: Experts

North Sunflower Medical Center to deploy McKesson health IT solutions

Omthera reaches agreement with FDA on SPA for Epanova Phase III trial in patients with very high triglycerides

Profil Institute expands capabilities to detect cardiac safety signals in diabetes and obesity clinical trials

Interim results from H.P. Acthar Gel study in patients with advanced diabetic nephropathy

Stealth Peptides introduces Bendavia clinical candidate at AHA Scientific Sessions

New study links high prevalence of insomnia and poor quality of life in software engineers

VYTORIN reduces major vascular events in patients with chronic kidney disease

Unlocking drug amorphization: Continuous, solvent-free twin screw granulation

How can super-resolution technology help study neurotransmission?

The Proteoform Puzzle: Unlocking the Next Frontier

Heart Disease News and Research

Latest Heart Disease News and Research

Unlocking drug amorphization: Continuous, solvent-free twin screw granulation

How can super-resolution technology help study neurotransmission?

The Proteoform Puzzle: Unlocking the Next Frontier

Newsletters you may be interested in